OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.01 Cr | ₹-0.05 Cr | ₹-0.29 Cr | ₹0.33 Cr | ₹0.10 Cr |
What is the latest Net Cash Inflow / Outflow ratio of OXYGENTA PHARMACEUTICAL ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.01 Cr |
Mar2023 | ₹-0.05 Cr |
Mar2022 | ₹-0.29 Cr |
Mar2021 | ₹0.33 Cr |
Mar2020 | ₹0.10 Cr |
How is Net Cash Inflow / Outflow of OXYGENTA PHARMACEUTICAL Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.01 Cr | Negative | |
Mar2023 | ₹-0.05 Cr | Negative | |
Mar2022 | ₹-0.29 Cr | Negative | |
Mar2021 | ₹0.33 Cr | 227.00 | |
Mar2020 | ₹0.10 Cr | - |
Compare Net Cash Inflow / Outflow of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹358.0 Cr | 7.8% | 13.3% | 180.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,125.0 Cr | 0.1% | -9.1% | 13.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,358.0 Cr | -1.6% | 6.5% | 47% | Stock Analytics | |
CIPLA | ₹118,957.0 Cr | 0.3% | -4.6% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,087.0 Cr | -0.9% | -4.5% | 15.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,197.0 Cr | 0.4% | 6.5% | 4.1% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | 7.8% |
13.3% |
180.3% |
SENSEX | -1% |
0.3% |
7.4% |
You may also like the below Video Courses